A Future for Autologous Hematopoietic Stem Cell Transplantation in Type 1 Diabetes
Summary
No alternative intervention strategies match, or even get close to, the clinical outcome achieved in a considerable number of patients treated with autologous stem cell transplantation. We propose that this patient group should be identified, diligently informed and offered the possible benefits of an extended period of insulin-free and burden-free survival,
Access Original Research
View the complete study and detailed methodology from the original source.
Read Full Study →Related Articles
Autologous mesenchymal stem cells offer a new paradigm for salivary gland regeneration
Over 60% of patients receiving treatment for head and neck cancers experience radiation-induced salivary gland damage. The study suggests this could provide a definitive treatment rather than just symptom management for the millions of people suffering from dry mouth conditions.
Randomized controlled study for the anti-aging effect of human adipocyte-derived mesenchymal stem cell media combined with niacinamide after laser therapy
The combination of stem cells and niacinimide improved skin through multiple mechanisms - reducing inflammation, protecting collagen structure, promoting collagen production, and enhancing skin repair - resulting in measurable improvements in wrinkles, pigmentation, and overall skin appearance that both patients and doctors could observe.
Innovative method of alopecia treatment by autologous adipose-derived SVF
Hair density and keratin significantly increased after one injection of stem cells.